Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain

Ageing Research Reviews

Volumn 9, Issue 3, 2010, Pages 273-279

  Balietti, Marta ^a   Casoli, Tiziana ^a   Di Stefano, Giuseppina ^a   Giorgetti, Belinda ^a   Aicardi, Giorgio ^b   Fattoretti, Patrizia ^a  

^a INRCA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aging; Epilepsy; Ketogenic diets; Neurodegeneration; Neuroprotection

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AC 1202; ACETOACETIC ACID; ACETYL COENZYME A ACETYLTRANSFERASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DOPAMINE BETA MONOOXYGENASE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUTAMIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE; MITOCHONDRIAL DNA; MONOCARBOXYLATE TRANSPORTER; NOOTROPIC AGENT; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

AGE; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CALORIC RESTRICTION; DIET RESTRICTION; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; KETOGENIC DIET; KETONURIA; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIMARY PREVENTION; REVIEW; THERAPY EFFECT; TREATMENT RESPONSE;

AGING; ANIMALS; EPILEPSY; HUMANS; KETOGENIC DIET; NEURODEGENERATIVE DISEASES;

RATTUS;

EID: 77952549736     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2010.02.003     Document Type: Review

References (122)

1. Adam P.A., Raiha N., Rahiala E.L., and Kekomaki M. Oxidation of glucose and D-B-OH-butyrate by the early human fetal brain. Acta Paediatr. Scand. 64 (1975) 17-24
2. Aicardi G., Argilli E., Cappello S., Santi S., Riccio M., Thoenen H., and Canossa M. Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15788-15792
3. Al-Khalifa A., Mathew T.C., Al-Zaid N.S., Mathew E., and Dashti H.M. Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition 25 (2009) 1177-1185
4. Appelberg K.S., Houda D.A., and Prins M.L. The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult controlled cortical impact injury in the juvenile and adult rat. J. Neurotrauma 26 (2009) 497-506
5. Balietti M., Fatoretti P., Giorgetti B., Casoli T., Di Stefano G., Solazzi M., Platano D., Aicardi G., and Bertoni-Freddari C. A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. Ann. N.Y. Acad. Sci. 1171 (2009) 377-384
6. Balietti M., Fattoretti P., Giorgetti B., Casoli T., Di Stefano G., Platano D., Aicardi G., Lattanzio F., and Bertoni-Freddari C. Effect of two medium chain triglycerides-supplemented diets on synaptic morphology in the cerebellar cortex of late-adult rats. Microsc. Res. Tech. 72 (2009) 933-938
7. Balietti M., Giorgetti B., Di Stefano G., Casoli T., Platano D., Solazzi M., Bertoni-Freddari C., Aicardi G., Lattanzio F., and Fattoretti P. A ketogenic diet increases succinic dehydrogenase (SDH) activity and recovers age-related decrease in numeric density of SDH-positive mitochondria in cerebellar Purkinje cells of late-adult rats. Micron 41 (2010) 143-148
8. Balietti M., Giorgetti B., Fattoretti P., Grossi Y., Di Stefano G., Casoli T., Platano D., Solazzi M., Orlando F., Aicardi G., and Bertoni-Freddari C. Ketogenic diets cause opposing changes in synaptic morphology in CA1 hippocampus and dentate gyrus of late-adult rats. Rejuvenation Res. 11 (2008) 631-640
9. Barborka C.J. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch. Neurol. 6 (1930) 904-914
10. Bertoni-Freddari C., Mocchegiani E., Malavolta M., Casoli T., Di Stefano G., and Fattoretti P. Synaptic and mitochondrial physiopathologic changes in the aging nervous system and the role of zinc ion homeostasis. Mech. Ageing Dev. 127 (2006) 590-596
11. Blazquez C., Sanchez C., Velasco G., and Guzman M. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes. J. Neurochem. 71 (1998) 1597-1606
12. Blazquez C., Sanchez C., Daza A., Galve-Roperh I., and Guzman M. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J. Neurochem. 72 (1999) 1759-1768
13. Blazquez C., Woods A., de Caballos M.L., Carling D., and Guzman M. The AMP-activated protein kinase involved in the regulation of ketone body production by astrocytes. J. Neurochem. 73 (1999) 1674-1682
14. Booth R.F., Patel T.B., and Clark J.B. The developmental of enzymes of energy metabolism in the brain of a precocial (guinea pig) and non-precocial (rat) species. J. Neurochem. 34 (1980) 17-25
15. Bough K. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia 49 Suppl. 8 (2008) 91-93
16. Bough K.J., and Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007) 43-58
17. Bough K.J., Valiyil R., Han F.T., and Eagles D.A. Seizure resistance is dependent upon age and caloric restriction in rats fed a ketogenic diet. Epilepsy Res. 35 (1999) 21-28
18. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., Shaw R., Smith Y., Geiger J.D., and Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60 (2006) 223-235
19. Buckley B.M., and Williamson D.H. Acetoacetate and brain lipogenesis: developmental pattern of acetoacetyl-coenzyme A synthetase in the soluble fraction of rat brain. Biochem. J. 132 (1973) 653-656
20. Calabrese V., Scapagnini G., Giuffrida Stella A.M., Bates T.E., and Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26 (2001) 739-764
21. Cheng B., Yang X., An L., Gao B., Liu X., and Liu S. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. Brain Res. 1286 (2009) 23-31
22. Contestabile A. Benefits of caloric restriction on brain aging and related pathological states: understanding mechanisms to devise novel therapies. Curr. Med. Chem. 16 (2009) 350-361
23. Coppola G., Veggiotti P., Cusmai R., Bertoli S., Cardinali S., DionisI-Vici C., Elia M., Lispi M.L., Sarnelli C., Tagliabue A., Toraldo C., and Pancotto A. The ketogenic diet in children, adolescent and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res. 48 (2002) 221-227
24. Cornejo V.E., Cabello J.F., Colombo M.C., and Raimann E.B. Glucose transporter type 1 deficiency syndrome (GLUT-1 SD) treated with ketogenic diet. Report of one case. Rev. Med. Chil. 135 (2007) 631-635
25. Cullingford T.E., Dolphin C.T., Bhakoo K.K., Peuchen S., Canevari L., and Clark J.B. Molecular cloning of rat mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase and detection of the corresponding mRNA and of those encoding the remaining enzymes comprising the ketogenic 3-hydroxy-3-methylglutaryl-CoA cycle in central nervous system of suckling rat. Biochem. J. 329 (1998) 373-381
26. Cullingford T.E., Eagles D.A., and Sato H. The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 49 (2002) 99-107
27. Cunnane S.C., Musa K., Ryan M.A., Whiting S., and Frase r.D.D. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostagl Leukotr. Essent Fatty Acids 67 (2002) 131-135
28. Dashti H.M., Al-Zaid N.S., Mathew T.C., Al-Mousawi M., Talib H., Asfar S.K., and Behbahani A.L. Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol. Cell. Biochem. 28 (2006) 1-9
29. Dashti H.M., Bo-Abbas Y.Y., Asfar S.K., Mathew T.C., Hussein T., Behbahani A., Khoursheed M.A., Al-Sayer H.M., and Al-Zaid N.S. Ketogenic diet modifies the risk factor of heart disease in obese patients. Nutrition 19 (2003) 901-902
30. Fraser D.D., Whiting S., Andrew R.D., Macdonald E.A., Mus-Veloso K., and Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60 (2003) 1026-1029
31. Freedland S.J., Mavropoulos J., Wang A., Darshan M., Demark-Wahnefried W., Aronson W.J., Cohen P., Hwang D., Peterson B., Fields T., Pizzo S.V., and Isaacs W.B. Carbohydrate restriction, prostate cancer growth, and insulin-like growth factor axis. Prostate 68 (2008) 11-19
32. Freeman J.M., Freeman J.B., and Kelly M.T. The Ketogenic Diet: A Treatment for Epilepsy. 3rd ed. (2000), Demos, New York
33. Freeman J.M., Kossoff E.H., and Hartman A.L. The ketogenic diet: one decade later. Pediatrics 119 (2007) 535-543
34. Freemantle E., Vandal M., Tremblay Mercier J., Plourde M., Poirier J., and Cunnane S.C. Metabolic response to a ketogenic breakfast in the healthy elderly. J. Nutr. Health Aging 13 (2009) 293-298
35. Garriga-Canut M., Schoenike B., Qazi R., Bergendahl K., Daley T.J., Pfender R.M., Morrison J.F., Ockuly J., Stafstrom C., Sutula T., and Roopra A. 2-Deoxy-d-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9 (2006) 1382-1387
36. Gasior M., Rogawski M.A., and Hartman A.L. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol. 17 (2006) 431-439
37. Gerhart D.Z., Enerson B.E., Zhdankina O.Y., Leino R.L., and Drewes L.R. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am. J. Physiol. 273 (1997) E207-213
38. Greene A.E., Todorova M.T., McGowan R., and Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 42 (2001) 1371-1378
39. Greene A.E., Todorova M.T., and Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J. Neurochem. 86 (2003) 529-537
40. Hamdy R.F., Turner Z., Pyzik P.L., and Kossoff E.H. Lack of influence of body mass index on the efficacy of the ketogenic diet. J. Child. Neurol. 22 (2007) 1167-1171
41. Harney J.P., Madara J., Madara J., and l'Anson H. Effects of acute inhibition of fatty acid oxidation on latency to seizure and concentrations of beta hydroxybutyrate in plasma of rats maintained on calorie restriction and/or the ketogenic diet. Epilepsy Res. 49 (2002) 239-246
42. Haymond M.W., Howard C., Ben-Galim E., and DeVivo D.C. Effects of ketosis on glucose flux in children and adults. Am. J. Physiol. 245 (1983) E373-E378
43. Hegardt F. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 338 (1999) 569-582
44. Henderson S.T., Vogel J.L., Barr L.J., Garvin F., Jones J.J., and Costantini L.C. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 6 (2009) 31
45. Hu Z.G., Wang H.D., Jin W., and Yin H.X. Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Ann. Clin. Lab. Sci. 39 (2009) 76-83
46. Imamura K., Takeshima T., Kashiwaya Y., Nakaso K., and Nakashima K. d-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in rotenone model of Parkinson's disease. J. Neurosci. Res. 84 (2006) 1376-1384
47. Jarrett S.G., Milder J.B., Liang L.P., and Patel M. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 106 (2008) 1044-1051
48. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., and Veech R.L. d-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5440-5544
49. Kennedy A.R., Pissios P., Out H., Roberson R., Xue B., Asakura K., Furukawa N., Marino F.E., Liu F.F., Kahn B.B., Libermann T.A., and Maratos-Flier E. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1724-1739
50. Kim do Y., Davis L.M., Sullivan P.G., Maalouf M., Simeone T.A., van Brederode J., and Rho J.M. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 101 (2007) 1316-1326
51. Klepper J., Scheffer H., Leiendecker B., Gertsen E., Binder S., Leferink M., Hertzberg C., Nake A., Voit T., and Willemsen M.A. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics 36 (2005) 302-308
52. Kossoff E.H., Rowley H., Sinha S.R., and Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 49 (2008) 316-319
53. Kossoff E.H., Zupec-Kania B.A., and Rho J.M. Ketogenic diets: an update for child neurologist. J. Child. Neurol. 24 (2009) 979-988
54. Kraus H., Schlenker S., and Schwedesky D. Developmental changes of cerebral ketone body utilization in human infants. Hoppe Seylers Z. Physiol. Chem. 355 (1974) 164-170
55. Lamprecht R., and LeDoux J. Structural plasticity and memory. Nat. Rev. Neurosci. 5 (2004) 45-54
56. Leino R.L., Gerhart D.Z., and Drewes L.R. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res. Dev. Brain Res. 113 (1999) 47-54
57. Leino R.L., Gerhart D.Z., Duelli R., Enerson B.E., and Drewes L.R. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38 (2001) 519-527
58. Likhodii S., Nylen K., and Burnham W.M. Acetone as an anticonvulsant. Epilepsia 49 Suppl. 8 (2008) 83-86
59. Likhodii S.S., Musa K., Mendonca A., Dell C., Burnham W.M., and Cunnane S.C. Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 41 (2000) 1400-1410
60. Liu Y.M. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia 49 Suppl. 8 (2008) 33-36
61. Lockwood E.A., and Bailey E. The course of ketosis and the activity of key enzymes of ketogenesis and ketone-body utilization during development of the postnatal rat. Biochem. J. 124 (1971) 249-254
62. Maalouf M., Rho J.M., and Mattson M.P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 59 (2009) 293-315
63. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., and Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145 (2007) 256-264
64. Mady M.A., Kossoff E.H., McGregor A.L., Wheless J.W., Pyzik P.L., and Freeman J.M. The ketogenic diet: adolescents can do it, too. Epilepsia 44 (2003) 847-851
65. Mantis J.G., Centeno N.A., Todorova M.T., McGowan R., and Seyfried T.N. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab. (Lond.) 1 1 (2004) 11
66. Massieu L., Haces M.L., Montiel T., and Hernandez-Fonseca K. Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolisis inhibition. Neuroscience 120 (2003) 365-378
67. Masuda R., Monahan J.W., and Kashiwaya Y. D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J. Neurosci. Res. 80 (2005) 501-509
68. Mattson M.P., and Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7 (2006) 278-294
69. McEwen B.S., and Reagan L.P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur. J. Pharmacol. 490 (2004) 13-24
70. Middleton B. The acetoacetyl-coenzyme A thiolases of rat brain and their relative activities during postnatal development. Biochem. J. 132 (1973) 731-737
71. Morris A.A. Cerebral ketone body metabolism. J. Inherit. Metab. Dis. 28 (2005) 109-121
72. Muller-Schwarze A.B., Tandon P., Liu Z., Yang Y., Holmes G.L., and Stafstrom C.E. Ketogenic diet reduces spontaneous seizure and mossy fiber sprouting in the kainic acid model. Neuroreport 10 (1999) 1517-1522
73. Murphy P., Likhodii S.S., Hatamian M., and McIntyre Burnham W. Effect of the ketogenic diet on the activity level of Wistar rats. Pediatr. Res. 57 (2005) 353-357
74. Nehlig A. Age-dependent pathways of brain energy metabolism: the suckling rat, a natural model of the ketogenic diet. Epilepsy Res. 37 (1999) 211-221
75. Noh H.S., Hah Y.S., Nilufar R., Han J., Bong J.H., Kang S.S., Cho G.J., and Choi W.S. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J. Neurosci. Res. 83 (2006) 702-709
76. Nylen K., Velazquez J.L., Sayed V., Gibson K.M., Burnham W.M., and Snead III O.C. The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1(-/-) mice. Biochim. Biophys. Acta 1790 (2009) 208-212
77. Otto C., Kaemmerer U., Illert B., Muehling B., Pfetzer N., Witting R., Voelker H.U., Thied eA., and Coy J.F. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain tryglicerides. B.M.C. Cancer 8 (2008) 122
78. Pang P.T., and Lu B. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res. Rev. 3 (2004) 407-430
79. Pellerin L., Bergersen L.H., Halestrap A.P., and Pierre K. Cellular and subcellular distribution of monocarboxylate transporter in cultured brain cells and in the adult brain. J. Neurosci. Res. 79 (2005) 55-64
80. Pellerin L., Pellegri G., Martin J.L., and Magistretti P.J. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs adult brain. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3990-3995
81. Prins M.L., Fujima L.S., and Hovda D.A. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J. Neurosci. Res. 82 (2005) 413-420
82. Prins M.L., and Giza C.C. Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev. Neurosci. 28 (2006) 447-456
83. Puchowicz M.A., Zechel J.L., Valerio J., Emancipator D.S., Xu K., Pundik S., LaManna J.C., and Lust W.D. Neuroprotection in diet-induced ketogenic rat brain after focal ischemia. J. Cereb. Blood Flow Metab. 28 (2008) 1007-1916
84. Raffo E., Francois J., Ferrandon A., Koning E., and Nehlig A. Calorie-restricted ketogenic diet increases thresholds to all patterns of pentylenetetrazol-induced seizures: critical importance of electroclinical assessment. Epilepsia 49 (2008) 320-328
85. Rafiki A., Boulland J.L., Halestrap A.P., Ottersen O.P., and Bergersen L. Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience 122 (2003) 677-688
86. Reger M.A., Henderson S.T., Hale C., Cholerton B., Baker L.D., Watson G.S., Hyde K., Chapman D., and Craft S. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging 25 (2004) 311-314
87. Rho J.M., Anderson G.D., Donevan S.D., and White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-β-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43 (2002) 358-361
88. Ribeiro L.C., Chitto A.L., Muller A.P., Rocha J.K., Castro da Silva M., Quincozes-Santos A., Nardin P., Rotta L.N., Ziegler D.R., Goncalves C.A., Da Silva R.S., Perry M.L., and Gottfried C. Ketogenic diet-fed rats have increased fat mass and phosphoenolpyruvate carboxykinase activity. Mol. Nutr. Food Res. 52 (2008) 1365-1371
89. Santi S., Cappello S., Riccio M., Bergami M., Aicardi G., Schenk U., Matteoli M., and Canossa M. Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance. EMBO J. 25 (2006) 4372-4380
90. Sas K., Robotka H., Toldi J., and Vecsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegeneration disorders. J. Neurol. Sci. 257 (2007) 221-239
91. Sato K., Kashiwaya Y., Keon C.A., Tsuchiya N., King M.T., Radda G.K., Chance B., Clarke K., and Veech R.L. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9 (1995) 651-658
92. Schank J.R., Liles L.C., and Weinshenker D. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice. Epilepsy Res. 65 (2005) 23-31
93. Seyfried T.N., Kiebish M., Mukherjee P., and Marsh J. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia 49 Suppl. 8 (2008) 114-116
94. Sirven J., Whedon B., Caplan D., Liporace J., Glosser D., O'Dwyer J., and Sperling M.R. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 40 (1999) 1721-1726
95. Sokoloff L. Metabolism of ketone bodies by the brain. Annu. Rev. Med. 24 (1973) 271-280
96. Soulé J., Messaoudi E., and Bramham C.R. Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem. Soc. Trans. 34 Pt 4 (2006) 600-604
97. Stafstrom C.E. Animal models of the ketogenic diet: what have we learned, what can we learn?. Epilepsy Res. 37 (1999) 241-259
98. Studzinski C.M., MacKay W.A., Beckett T.L., Henderson S.T., Murphy M.P., Sullivan P.G., and Burnham W.M. Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in aged dogs. Brain Res. 1226 (2008) 209-217
99. Sullivan P.G., Rippy N.A., Dorenbos K., Concepcion R.C., Agarwal A.K., and Rho J.M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55 (2004) 576-580
100. Szot P., Weinshenker D., Rho J.M., Storey T.W., and Schwartzkroin P.A. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res. Dev. Brain Res. 129 (2001) 211-214
101. Taha A.Y., Ryan M.A., and Cunnane S.C. Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 54 (2005) 1127-1132
102. Tai K.K., Nguyen N., Pham L., and Truong D.D. Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration. J. Neural. Transm. 115 (2008) 1011-1017
103. Thio L.L., Wong M., and Yamada K.A. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54 (2000) 325-331
104. Tieu K., Perier C., Caspersen C., Teismann P., Wu D.C., Yan S.D., Naini A., Vila M., Jackson-Lewis V., Ramasamy R., and Przedborski S. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112 (2003) 892-901
105. Toescu E.C., Myronova N., and Verkhratsky A. Age-related structural and functional changes of brain mitochondria. Cell Calcium 28 (2000) 329-338
106. Vamecq J., Vallee L., Lesage F., Gressens P., and Stables J.P. Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Prog. Neurobiol. 75 (2005) 1-28
107. Van der Auwera I., Wera S., Van Leuven F., and Henderson S.T. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr. Metab. (Lond.) 17 2 (2005) 28
108. VanItallie T.B., Nonas C., Di Rocco A., Boyar K., Hyams K., and Heymsfield S.B. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 64 (2005) 728-730
109. Vannucci S.J. Developmental expression of GLUT1 and GLUT3 glucose transporters in rat brain. J. Neurochem. 62 (1994) 240-246
110. Vannucci S.J., and Simpson I.A. Developmental switch in brain nutrient transporter expression in the rat. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E1127-1134
111. Veech R.L., Chance B., Kashiwaya Y., Lardy H.A., and Cahill Jr. G.F. Ketone bodies, potential therapeutic uses. IUBMB Life 51 (2001) 241-247
112. Voskuyl R.A., Vreugdenhil M., Kang J.X., and Leaf A. Anticonvulsant effects of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur. J. Pharmacol. 341 (1998) 145-152
113. Weinshenker D. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia 49 Suppl. 8 (2008) 104-107
114. Weinshenker D., and Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Ther. 94 (2002) 213-233
115. Westman E.C., Yancy Jr. W.S., Mavropoulos J.C., Marquart M., and McDuffie J.R. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr. Metab. (Lond.) 5 (2008) 36
116. Wheless J.W. History of the ketogenic diet. Epilepsia 49 Suppl. 8 (2008) 3-5
117. Wilder R.M. The effects of ketonemia on the corse of epilepsy. Mayo Clin. Bull. 2 (1921) 307-308
118. Williamson D.H., Bates M.W., Page M.A., and Krebs H.A. Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem. J. 121 (1971) 41-47
119. Xu X.P., Erichsen D., Borjesson S.I., Dahlin M., Amark P., and Elinder F. Polyunsaturated fatty acids and cerebrospinal fluid from children on the ketogenic diet open a voltage-gated K channel: a putative mechanism of antiseizure action. Epilepsy Res. 80 (2008) 57-66
120. Yeh Y.Y., and Zee P. Insulin, a possible regulator of ketosis in newborn and suckling rats. Pediatr. Res. 10 (1976) 192-197
121. Yudkoff M., Daikhin Y., Horyn O., Nissim I., and Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 49 Suppl. 8 (2008) 73-75
122. Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., Humala N., Thiyagarajan M., Wang J., and Pasinetti G.M. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. B.M.C. Neurosci. 7 (2006) 29